Aligning Cancer Research Priorities in Europe with Recommendations for Conquering Cancer: A Comprehensive Analysis-Reference-Cited by-同舟云学术

Aligning Cancer Research Priorities in Europe with Recommendations for Conquering Cancer: A Comprehensive Analysis

Published:2024-01-19 Issue:2 Volume:12 Page:259
ISSN:2227-9032
Container-title:Healthcare
language:en
Short-container-title:Healthcare

Author:

Horgan Denis¹²,Bulcke Marc Van den³,Malapelle Umberto⁴^ORCID,Normanno Nicola⁵^ORCID,Capoluongo Ettore D.⁶⁷,Prelaj Arsela⁸^ORCID,Rizzari Carmelo⁹^ORCID,Stathopoulou Aliki¹⁰,Singh Jaya¹,Kozaric Marta¹,Dube France¹¹,Ottaviano Manuel¹²,Boccia Stefania¹³¹⁴^ORCID,Pravettoni Gabriella¹⁵¹⁶,Cattaneo Ivana¹⁷,Malats Núria¹⁸^ORCID,Buettner Reinhard¹⁹^ORCID,Lekadir Karim²⁰,de Lorenzo Francesco¹⁰,Blanc Patricia²¹,Alix-Panabieres Catherine²²^ORCID,Badreh Sara²³,Hofman Paul²⁴^ORCID,Solary Eric²⁵²⁶²⁷^ORCID,De Maria Ruggero²⁸

Affiliation:

1. European Alliance for Personalised Medicine, 1040 Brussels, Belgium

2. Department of Molecular and Cellular Engineering, Jacob Institute of Biotechnology and Bioengineering, Faculty of Engineering and Technology, Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj 211007, India

3. Belgian Cancer Centre, Sciensano, 1050 Brussels, Belgium

4. Department of Public Health, University Federico II of Naples, 80138 Naples, Italy

5. Istituto Nazionale Tumori “Fondazione G. Pascale”—IRCCS, 80131 Naples, Italy

6. Dipartimento di Eccellenza in Medicina Molecolare e Biotecnologie Mediche, Università Federico II, 80138 Naples, Italy

7. Department of Clinical Pathology and Genomics, Azienda Ospedaliera Per L’Emergenza Cannizzaro, 95126 Catania, Italy

8. Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy

9. Unità di Ematologia Pediatrica, Fondazione MBBM, Università di Milano-Bicocca, 20126 Monza, Italy

10. European Cancer Patient Coalition, 1000 Brussels, Belgium

11. Astra Zeneca, Concord Pike, Wilmington, DE 19803, USA

12. Departamento de Tecnología Fotónica y Bioingeniería, Universidad Politècnica de Madrid, 28040 Madrid, Spain

13. Section of Hygiene, Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, 20123 Rome, Italy

14. Departments of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy

15. Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy

16. Applied Research Division for Cognitive and Psychological Science, European Institute of Oncology (IEO) IRCCS, 20139 Milan, Italy

17. Novartis Farma SpA, 20154 Milano, Italy

18. Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain

19. Lung Cancer Group Cologne, Institute of Pathology and Medical Faculty, Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, 50937 Cologne, Germany

20. Artificial Intelligence in Medicine Lab (BCN-AIM), Universitat de Barcelona, 08007 Barcelona, Spain

21. Imagine for Margo, 78100 Saint-Germain-en-Laye, France

22. Laboratory of Rare Human Circulating Cells, University Medical Center of Montpellier, 34093 Montpellier, France

23. Cancer Childhood International, 1200 Vienna, Austria

24. Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Université Côte d’Azur, 06000 Nice, France

25. INSERM U1287, Gustave Roussy Cancer Campus, 94805 Villejuif, France

26. Faculty of Medicine, Université Paris-Sud, Le Kremlin-Bicêtre, 91405 Île-de-France, France

27. Department of Hematology, Gustave Roussy Cancer Campus, 94805 Paris, France

28. Institute of General Pathology, Catholic University of the Sacred Heart, 20123 Rome, Italy

Abstract

Improvements in cancer care require a new degree of collaboration beyond the purely medical sphere, extending deeply into the world of other stakeholders—preeminently patients but also the other stakeholders in the hardware and software of care. Cancer remains a global health challenge, necessitating collaborative efforts to understand, prevent, and treat this complex disease. To achieve this goal, a comprehensive analysis was conducted, aligning the prioritization of cancer research measures in 13 European countries with 13 key recommendations for conquering cancer in the region. The study utilized a survey involving both patients and citizens, alongside data from IQVIA, a global healthcare data provider, to assess the availability and access to single-biomarker tests in multiple European countries. The results revealed a focused approach toward understanding, preventing, and treating cancer, with each country emphasizing specific research measures tailored to its strengths and healthcare objectives. This analysis highlights the intricate relationship between research priorities, access to biomarker tests, and financial support. Timely access to tests and increased availability positively influence research areas such as cancer prevention, early detection, ageing, and data utilization. The alignment of these country-specific measures with 13 recommendations for conquering cancer in Europe underscores the importance of tailored strategies for understanding, preventing, and treating cancer.

Funder

European Union

European Commission

Publisher

MDPI AG

Link

https://www.mdpi.com/2227-9032/12/2/259/pdf

Reference38 articles.

1. Cancer Screening and Early Detection in the 21st Century;Loud;Semin. Oncol. Nurs.,2017

2. Early detection of cancer;Crosby;Science,2022

3. The use of Big Data Analytics in healthcare;Batko;J. Big Data,2022

4. European Commission (2023, November 03). Europe’s Beating Cancer Plan. Available online: https://health.ec.europa.eu/system/files/2022-02/eu_cancer-plan_en_0.pdf.

5. Horgan, D., Baird, A.M., Middleton, M., Mihaylova, Z., Van Meerbeeck, J.P., Vogel-Claussen, J., Van Schil, P.E., Malvehy, J., Ascierto, P.A., and Dube, F. (2022). How Can the EU Beating Cancer Plan Help in Tackling Lung Cancer, Colorectal Cancer, Breast Cancer and Melanoma?. Healthcare, 10.